TotalMarketCap

Market cap

$3.461 B

$30.48 -2.46%

Close of 13 Nov 2026

As of 13 Nov 2026, Viridian Therapeutics, Inc.DE (VRDN) has a market capitalization of $3.46B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$342.6M

Loss-making

Shares outstanding

113,558,449

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 497 →
  1. #68Viking TherapeuticsVKTX$3.52B
  2. #69Arcutis BiotherapeuticsARQT$3.48B
  3. #70Viridian Therapeutics, Inc.DEVRDN$3.46B
  4. #71Parabilis MedicinesPBLS$3.42B
  5. #72Dyne TherapeuticsDYN$3.19B

What if Viridian Therapeutics, Inc.DE were worth as much as…

Open the what-if tool →

Or at a round number

Where these numbers come from

Share counts and financials for Viridian Therapeutics, Inc.DE are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.